Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma
Clinical trial NCT01659151 · COMPLETED
Trial details
- NCT number
- NCT01659151
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-03
- Primary completion
- 2021-10-06
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.